{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:24:12Z","timestamp":1794947052583,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127489","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T16:35:02Z","timestamp":1752597302000},"page":"127489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["From controversy to confidence: Strengthening dengue vaccines safety reporting"],"prefix":"10.1016","volume":"62","author":[{"given":"Le","family":"Van Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thi","family":"Thuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Thanh","family":"Hien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam Q.M.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeza Muhamad Abdul","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seshini","family":"Mahabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc Nghia","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Thi Thu","family":"Trang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tien","family":"Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127489_bb0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0042-6822(90)90102-W","article-title":"Molecular evolution and distribution of dengue viruses type 1 and 2 in nature","volume":"174","author":"Rico-Hesse","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127489_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/1995-7645.223529","article-title":"Scenario of dengue infection & its control in Pakistan: an up\u2014date and way forward","volume":"11","author":"Yousaf","year":"2018","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0002-9343(51)90035-6","article-title":"An account of the bilious remitting fever","volume":"11","author":"Rush","year":"1951","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4269\/ajtmh.1986.35.642","article-title":"Dengue in Greece in 1927 and 1928 and the pathogenesis of dengue Hemorrhagic fever: new data and a different conclusion","volume":"35","author":"Rosen","year":"1986","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.127489_bb0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ebiom.2016.03.046","article-title":"Climate change and Aedes vectors: 21st century projections for dengue transmission in Europe","volume":"7","author":"Liu-Helmersson","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2025.127489_bb0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1289\/EHP218","article-title":"An analysis of the potential impact of climate change on dengue transmission in the Southeastern United States","volume":"125","author":"Butterworth","year":"2017","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.vaccine.2025.127489_bb0035","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jiph.2023.08.001","article-title":"Dengue overview: an updated systemic review","volume":"16","author":"Khan","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2025.127489_bb0040","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1186\/s12879-021-06685-5","article-title":"A study on knowledge, attitudes and practices regarding dengue fever, its prevention and management among dengue patients presenting to a tertiary care hospital in Sri Lanka","volume":"21","author":"Jayawickreme","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127489_bb0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2017.00317","article-title":"Global epidemiology of dengue outbreaks in 1990\u20132015: A systematic review and Meta-analysis","volume":"7","author":"Guo","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.127489_bb0050","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127489_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40794-024-00231-2","article-title":"The role of antibody-dependent enhancement in dengue vaccination","volume":"10","author":"Aynekulu Mersha","year":"2024","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.vaccine.2025.127489_bb0065","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.91.7.2395","article-title":"Dengue: the risk to developed and developing countries","volume":"91","author":"Monath","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.127489_bb0070","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.127489_bb0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cmi.2018.01.018","article-title":"Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America","volume":"24","author":"Arredondo-Garc\u00eda","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2025.127489_bb0080","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127489_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","article-title":"Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD\u2122 vaccine?","volume":"15","author":"Whitehead","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127489_bb0095","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127489_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.580096","article-title":"Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection","volume":"10","author":"Narayan","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.127489_bb0105","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1016\/j.vaccine.2021.07.051","article-title":"Fear, mistrust, and vaccine hesitancy: narratives of the dengue vaccine controversy in the Philippines","volume":"39","author":"Yu","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127489_bb0110","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127489_bb0115","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0120","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2254964","article-title":"An open-label, phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life","volume":"19","author":"Patel","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127489_bb0125","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The vaccine adverse event reporting system (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127489_bb0130","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(98)03148-1","article-title":"150 years of pharmacovigilance","volume":"351","author":"Routledge","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127489_bb0135","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/14740338.2019.1669559","article-title":"Making medicines safer: analysis of patient reports to the UK\u2019S yellow card scheme","volume":"18","author":"O\u2019Donovan","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.vaccine.2025.127489_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043880","article-title":"Safety of live attenuated herpes zoster vaccine in Australian adults 70\u201379 years of age: an observational study using active surveillance","volume":"11","author":"Phillips","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127489_bb0145","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1016\/j.vaccine.2015.09.105","article-title":"Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine","volume":"33","author":"Precioso","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127489_bb0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.22146\/jmpf.87108","article-title":"Healthcare professionals\u2019 attitudes towards adverse drug reactions reporting in primary healthcare settings: A cross-sectional survey","volume":"14","author":"Yuniar","year":"2024","journal-title":"J Manaj dan Pelayanan Farm"},{"key":"10.1016\/j.vaccine.2025.127489_bb0155","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/vaccines12070770","article-title":"Immunogenicity, safety and efficacy of the dengue vaccine TAK-003: A Meta-analysis","volume":"12","author":"Flacco","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127489_bb0160","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1016\/j.vaccine.2020.06.079","article-title":"Ethics of a partially effective dengue vaccine: lessons from the Philippines","volume":"38","author":"Halstead","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127489_bb0165","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1186\/s12889-023-17005-8","article-title":"Acceptability of a hypothetical dengue vaccine and the potential impact of dengue vaccination on personal vector control behavior: a qualitative study in Fortaleza, Brazil","volume":"23","author":"Scott","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.127489_bb0170","series-title":"Dengvaxia: Lessons learned, public health imperatives","author":"Bulletin","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127489_bb0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/diseases12020032","article-title":"Dengue fever epidemics and the Prospect of vaccines: A systematic review and Meta-analysis using clinical trials in children","volume":"12","author":"Okoye","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.vaccine.2025.127489_bb0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/vaccines13020145","article-title":"Dengue vaccination: A practical guide for clinicians","volume":"13","author":"See","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127489_bb0190","first-page":"58","article-title":"The quest for an effective dengue vaccine: Hope or hype","volume":"25","author":"Chowdhury","year":"2024","journal-title":"J Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0195","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.36557\/pbpc.v3i2.253","article-title":"EFIC\u00c1CIA DAS VACINAS CONTRA DENGUE NA PREVEN\u00c7\u00c3O DA DOEN\u00c7A EM CRIAN\u00c7AS","volume":"3","author":"Rocha Cardoso Viana","year":"2024","journal-title":"PBPC"},{"key":"10.1016\/j.vaccine.2025.127489_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002181","article-title":"The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): A model comparison study","volume":"13","author":"Flasche","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2025.127489_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-023-00658-2","article-title":"Is new dengue vaccine efficacy data a relief or cause for concern?","volume":"8","author":"Thomas","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.127489_bb0210","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S2214-109X(23)00590-9","article-title":"TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden","volume":"12","author":"Wilder-Smith","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127489_bb0215","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1016\/S2214-109X(24)00226-2","article-title":"Delivering safe dengue vaccines","volume":"12","author":"Halstead","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127489_bb0220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40259-022-00531-z","article-title":"Dengue Vaccines: An Update","volume":"36","author":"Torres-Flores","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2025.127489_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1423044","article-title":"An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh\u2013A perspective","volume":"15","author":"Kayesh","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.127489_bb0230","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Tricou","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127489_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126407","article-title":"Safety signal detected: anaphylaxis after attenuated dengue vaccine (TAK-003) \u2013 Brazil, march 1, 2023-march 11, 2024","volume":"42","author":"Percio","year":"2024","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:18:37Z","timestamp":1766546317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0264410X25007868"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127489","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From controversy to confidence: Strengthening dengue vaccines safety reporting","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127489"}}